Metastasis is a multistep process in which cancer cells grow, become mobile, and disseminate, thereby leading to the development of secondary tumours at a distance from the original tumour. Understanding the mechanisms of metastasis is essential if we are to develop ways to block the formation of secondary tumours. Reporting in the July issue of Nature Cell Biology, Allan Balmain and colleagues at the University of California in San Francisco show that increasing the activation levels of the signalling molecules Smad2 and H-ras sequentially drives tumours through the different stages of becoming metastatic.
The TGF-beta and H-ras signalling pathways had previously been implicated in tumour progression. Now Oft et al. show that activating Smad2, one protein that works with TGF-beta, is sufficient to induce migration of tumour cells. Increasing the amount of H-ras is required, in addition to Smad2 activation, to drive resident epithelial-like cells to develop into mobile fibroblastoid-like cells. A further increase in Smad2 levels in these fibroblastoid-like cancer cells allows them to enter blood vessels and travel to other tissues. These findings have far-reaching implications for preventing secondary-tumour development.
Dr Allan Balmain
Cancer Research Institute
University of California
San Francisco, CA, USA
Tel: +1 415 502 4192
(C) Nature Cell Biology press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...